Evaluation of a 5-day High-Dose Course of Amoxicillin for the Management of Community-Acquired Pneumonia in Children of 6 months to 10 years of Age
J Pediatric Infect Dis Soc
.
2022 Dec 5;11(11):480-481.
doi: 10.1093/jpids/piac025.
Authors
Torsten Joerger
1
,
Sanjeev K Swami
1
Affiliation
1
Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
PMID:
36260306
DOI:
10.1093/jpids/piac025
No abstract available
MeSH terms
Amoxicillin / therapeutic use
Anti-Bacterial Agents / therapeutic use
Child
Community-Acquired Infections* / drug therapy
Humans
Infant
Pneumonia* / drug therapy
Substances
Amoxicillin
Anti-Bacterial Agents